Health & WellnessTech

LifeBridge 10000, LLC

Transforming metastatic cancer from a terminal prognosis to a manageable disease like diabetes
Investment type:
Target raise:
 - $250,000
Minimum investment:​
End date:
Jan 15, 2022
Share on facebook
Share on twitter
Share on linkedin
Share on email

  • Our device can extend the proven benefits of Tumor Treating Fields (TTF) therapy to patients with metastatic cancer
  • On any given day 500,000+ cancer patients could be helped by our therapy. Without it they will die
  • Value creation! Tumor Treating Fields has experienced explosive growth up 736% since 2018 (Forbes)
  • We solve the limitations of the current therapy. 2 U.S. Patents 3rd pending. Pending in 36 counties
Our Story

When people with cancer get really sick all known medicines stop working and they are told to prepare to die. We are going to change that by building a device just for them. The device makes a therapy proven to work in patients with cancer in just one location, like the lungs, work in more than one location like the lung and liver at the same time. Best of all it treats cancer without making the patients feel sick or tired and they don't lose their hair.
Our Ambition

The addressable global market for our device is over six billion per year. Our goal in the next five years is to setup 20 centers of excellence strategically placed around the world. Collectively they will be able to produce $60,000,000 per year in revenue. At the same time the 20 centers will act as a base camp, so to speak, for launching a global effort to train 1000 oncologist per year in our therapy. This will enable the company to reach its full potential.